Early Intensive Versus Escalation Approaches for Relapsing-Remitting Multiple Sclerosis Long Term Extension

Overview

About this study

The purpose of this study is to answer the important question: Does early treatment with highly effective DMT (Disease Modifying Therapy) improve the prognosis for people with MS? This is an area of significant controversy and no data currently exist to guide treatment choices for patients and clinicians.  

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria: 

  • Participation in, and completion of Month-36 visit of the DELIVER MS trial (NCT# 03535298).
  • Provides informed consent to continue in the extension trial.
  • Willing to follow the protocol.

Exclusion Criteria:

  • Participants with clinically relevant medical or surgical conditions that, in the opinion of the investigator, would put the subject at risk by participating in the study
  • Unwillingness or inability to comply with the requirements of this protocol including the presence of any condition (physical, mental, or social) that, in the opinion of the PI, is likely to affect the participant's ability to comply with the study protocol.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 10/12/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Orhun Kantarci, M.D.

Closed-enrolling by invitation

What is this? (?)
"Close"
Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.

Contact information:

Melissa Bush

(507) 538-5418

Bush.Melissa1@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20568793

Mayo Clinic Footer